Printer Friendly

Smith & Nephew, Advanced Tissue Sciences announce Dermagraft receives CMS pass-through code.

Smith & Nephew pic, Largo, FL and Advanced Tissue Sciences, La Jolla, CA announced that Dermagraft Human Fibroblast-Derived Skin Substitute has received an Ambulatory payment Classification (APC) pass-through code under the Hospital Outpatient Prospective Payment System from the Centers for Medicare & Medicaid Services (CMS - formerly HCFA).

The companies say the pass-through payment code for Dermagraft (C 9201) covers Medicare patients with diabetic foot ulcers treated in a hospital out-patient setting. It will be effective January 1, 2002. The FDA cleared the PMA for Dermagraft in the treatment of foot ulcers for diabetics on September 28. Dermagraft is the first human-based cryopreserved, living dermal substitute approved by the lFDA.

Contact: Advanced Tissue Sciences - (619) 450-5730
COPYRIGHT 2001 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Smith & Nephew, Advanced Tissue Sciences announce Dermagraft receives CMS pass-through code.
Publication:Transplant News
Article Type:Brief Article
Geographic Code:1USA
Date:Dec 28, 2001
Previous Article:Baxter receives FDA clearance to market new pediatric peritoneal dialysis system.
Next Article:Cloned pigs with rejection gene eliminated raises hopes for breakthrough in xenotransplantation.

Related Articles
FDA approves IDE for Advanced Tissue Sciences to distribute Dermagraft to select US treatment centers.
Advanced Tissue Sciences reports on physiological properties of living vascular grafts.
Advanced Tissue Sciences receives patent for growing living cartilage with mesenchymal stem cells.
Advanced Tissue Sciences receives broad bioreactor patent.
Advanced Tissue Sciences, Smith & Nephew get FDA PMA approval for artificial skin product.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters